Web Results

www.oyez.org/cases/2010/09-152

Oct 12, 2010 ... Bruesewitz v. ... Wyeth, Inc., fka Wyeth Laboratories, et al. ... way to provide compensation to injured children without driving drug manufacturers ...

www.supremecourt.gov/opinions/10pdf/09-152.pdf

Feb 22, 2011 ... not merit a single mention in the Act or in Food and Drug Admini- ... RUSSELL BRUESEWITZ, ET AL., PETITIONERS v. WYETH LLC, FKA ...

caselaw.findlaw.com/us-supreme-court/09-152.html

Case opinion for US Supreme Court BRUESEWITZ ET AL. v. ... Design defects do not merit a single mention in the Act or in Food and Drug Administration ...

caselaw.findlaw.com/nj-supreme-court/1094741.html

The phrase appears to have been coined in the case of Sterling Drug, Inc. v. .... et al., The Learned Intermediary Doctrine: The Correct Prescription for Drug ...

www.law.cornell.edu/supct/cert/09-152

Oct 12, 2010 ... The Third Circuit Court of Appeals agreed with Wyeth and dismissed the claim. ... to avoid costly litigation that may drive them out of the vaccine market. ... and Drug Administration (“FDA”) and the Center for Disease Control and Prevention (“ CDC”). ... See Brief of Amici Curiae Glaxosmithkline LLC, et al.

respectfulinsolence.com/2011/02/23/the-supreme-court-rules-on-bruesewitz-v

Feb 23, 2011 ... Due to the fear that litigation might well drive vaccine manufacturers either out ... Then, in March 2010, SCOTUS agreed to hear Bruesewitz v. Wyeth. ...... under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] ...

search.rpxcorp.com/litigation_documents/12279350

Dec 23, 2016 ... Wyeth LLC, Wyeth Pharmaceuticals Inc. (“Wyeth Inc.”) and PF PRISM C.V.,. ( collectively .... did not contest personal jurisdiction); Sanofi et al. v.

www.nam.org/Advocacy/The-Center-for-Legal-Action/Briefs-Online/2017/NAM-Amicus-Brief-in-Rafferty-v-Merck-and-Co-(Mass-S-Ct)

Aug 25, 2017 ... Attorneys for Amici Curiae Pharmaceutical Research and. Manufacturers of ..... Supporting Petitioner, Wyeth v. Levine,. 555 U.S. ... Henry G. Grabowski et al., Updated Trends in .... TEConomy Partners LLC, Driving Innovation.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4847363

Apr 27, 2016 ... According to Paul et al. [12], drug R&D (across all therapeutic areas) takes on average 14 years [12]. Discovery research lasts for 4.5 years, ...